3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
14
Myelodysplastic Syndromes
6
Advanced Solid Tumors
5
Advanced Solid Tumour
4
Small Cell Lung Carcinoma
3
Recurrence
3
Myeloproliferative Disorders
3
Leukemia, Myelomonocytic, Chronic
3
Carcinoma, Non-Small-Cell Lung
3
Neoplasm Metastasis
2
Multiple Myeloma
2
Esophageal Squamous Cell Carcinoma
2
Advanced Solid Tumor
2
Advanced Breast Cancer
2
Unresectable Locally Recurrent Breast Cancer
1
Squamous Cell Carcinoma of Head and Neck
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Ovarian Neoplasms
1
Non-small Lung Cancer
1
Non-Muscle Invasive Bladder Neoplasms
1
Neuroma
1
Neoplasms
1
Nasopharyngeal Carcinoma
1
Multiple Sclerosis
1
Metastatic Solid Tumors
1
Lung Neoplasms
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Monocytic, Acute
1
Leukemia, Biphenotypic, Acute
1
Interventions
Cyclophosphamide
9
Nivolumab
8
pembrolizumab
7
fludarabine phosphate
7
fludarabine
6
Mycophenolic Acid
6
Magnetic Resonance Spectroscopy
6
Whole-Body Irradiation
5
Vinblastine
5
Granulocyte Colony-Stimulating Factor
5
Filgrastim
5
Doxorubicin
5
Dacarbazine
5
Cyclosporine
5
Brentuximab Vedotin
5
Melphalan
4
Busulfan
4
pegfilgrastim
3
Tacrolimus
3
Specimen Handling
3
Etoposide
3
Thiotepa
2
Sirolimus
2
Radiotherapy
2
Peripheral Blood Stem Cell Transplantation
2
Fluorodeoxyglucose F18
2
Cyclosporins
2
Clofarabine
2
Azacitidine
2
treosulfan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Hodgkin Disease
×
Injections
×
30 days
×
Clear all
No trials found.